Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
5.57
-0.29 (-4.95%)
At close: Nov 20, 2026, 4:00 PM EST
5.60
+0.03 (0.54%)
After-hours: Nov 20, 2026, 7:30 PM EST
Ocular Therapeutix Employees
Ocular Therapeutix had 325 employees as of December 31, 2025. The number of employees increased by 51 or 18.61% compared to the previous year. That makes Ocular Therapeutix the 23,262nd largest employer in the world and 2,984th in the United States.
Employees
325
Change (1Y)
51
Growth (1Y)
18.61%
Revenue / Employee
$155,028
Profits / Employee
-$1,005,572
Market Cap
1.23B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 325 | 51 | 18.61% |
| Dec 31, 2024 | 274 | 7 | 2.62% |
| Dec 31, 2023 | 267 | -7 | -2.55% |
| Dec 31, 2022 | 274 | 46 | 20.18% |
| Dec 31, 2021 | 228 | 47 | 25.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| MannKind | 592 |
| Absci | 140 |
| Taysha Gene Therapies | 99 |
| Silence Therapeutics | 88 |
| Mineralys Therapeutics | 76 |
| Vor Biopharma | 76 |
| GH Research | 73 |
OCUL News
- 2 days ago - Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 days ago - Ocular Therapeutix Transcript: UBS Global Biopharma Conference 2026 - Transcripts
- 11 days ago - Ocular Therapeutix price target raised to $28 from $25 at H.C. Wainwright - TheFly
- 13 days ago - Ocular Therapeutix Earnings Call Transcript: Q3 2026 - Transcripts
- 13 days ago - Ocular Therapeutix Earnings release: Q3 2026 - Filings
- 13 days ago - Ocular Therapeutix Quarterly report: Q3 2026 - Filings
- 13 days ago - Ocular Therapeutix reports Q3 EPS (42c), consensus (35c) - TheFly
- 13 days ago - Ocular Therapeutix™ Reports Third Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire